Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12 to 64 with at least one underlying ...

Sept 23 (Reuters) - Moderna (MRNA.O), opens new tab said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in ...

New and changing FDA and CDC guidance on COVID-19 vaccine eligibility has left many confused. Here's what to know about getting the shot this fall.

Moderna (NASDAQ:MRNA) updated data from a Phase 4 clinical trial for its redesigned COVID-19 vaccine, noting that the mRNA-based shot branded as mNEXSPIKE led to more than a 15-fold increase in ...

If you’ve been wondering, “When will the 2025 COVID vaccine be widely available?” you’re not alone. By this time last year, the 2024-25 COVID-19 vaccines had already been approved by the Food and Drug ...

On December 18, a San Diego emergency room nurse was given a shot of the COVID-19 vaccine. A week later, he tested positive for the virus, CNN affiliate KGTV reported. Stories like this will become ...

CHICAGO, Sept 29 (Reuters) - Results from an early safety study of Moderna Inc's (MRNA.O), opens new tab coronavirus vaccine candidate in older adults showed that it produced virus-neutralizing ...

CAMBRIDGE, Mass. — Moderna said on Tuesday its updated COVID-19 vaccine formulation elicited a strong immune response in all adults aged 65 and older, as well as in individuals aged 12-64 with at ...